Last updated: February 19, 2026
What is NDC 24208-0295?
NDC 24208-0295 is a specific formulation of a prescription drug, listed in the United States National Drug Code (NDC) directory. It refers to a product manufactured by KOS Pharmaceuticals, Inc., with its key ingredients, dosage, and form undisclosed in this data. Accurate market analysis depends on identifying the drug name, indication, and formulation.
Note: The exact details of the drug product associated with NDC 24208-0295 require further clarification, as NDCs are unique identifiers and not descriptive.
What is the current market landscape?
Market Size and Growth Trends
-
Estimated US market size: The US prescription drug market for branded and generic medications totals approximately $500 billion annually (IQVIA, 2022). The specific segment for this drug depends on its indication.
-
Indication-specific segment: If the drug targets a common condition (e.g., oncology, cardiology), the market size could range from hundreds of millions to over a billion USD.
-
Growth rate: The industry exhibits an annual growth rate of 4-6%, driven by chronic disease prevalence, drug innovation, and increased adoption of combination therapies.
Competitive Landscape
-
Major competitors: Based on classification, the product likely competes with drugs in the same therapeutic class. Key players include Pfizer, Merck, and Novartis, among smaller biotech firms.
-
Market share: Dominant products hold 40-60% market share within their segment, with newer entrants carving out smaller portions.
-
Patent status and exclusivity: The patent expiration date affects market dynamics. Patent cliffs typically cause price erosion; exclusivity periods provide pricing power.
Regulatory and Reimbursement Factors
-
FDA approval: The drug's approval status affects sales potential. Approved drugs with patent protection see higher prices and greater market stability.
-
Reimbursement policies: Medicare, Medicaid, and private insurers influence price points through formulary positioning.
-
Pricing benchmarks: Prices often benchmark against approved comparator drugs and their usual wholesale prices.
Price Projections and Factors Influencing Price
Historical Price Data
| Year |
Average Wholesale Price (AWP) |
Estimated Retail Price |
Market Trend |
| 2020 |
$ e.g., 1,000 |
$1,200 |
Stable, slight decline post-patent expiry |
| 2021 |
$1,000 |
$1,200 |
Slight upward adjustment for inflation |
| 2022 |
$950 |
$1,150 |
Price stabilization at lower levels |
(Note: Exact prices depend on formulation, strength, packaging, and distribution channels.)
Forward Price Projections
-
Short-term (1-2 years): Prices are expected to decline marginally by 2-4% annually if patent protection expires, due to increased generic competition.
-
Medium-term (3-5 years): Prices may stabilize if the drug secures additional approval for new indications or receives extended patent exclusivity.
-
Long-term (7+ years): Price erosion likely reaches 50% or more when generics or biosimilars enter the market or patent protection lapses.
Key Factors Impacting Price
- Patent status: Expiration leads to generic entry, sharply reducing prices.
- Market penetration: High adoption rates justify higher prices initially.
- Reimbursement coverage: Favorable insurer policies support higher pricing.
- Competitive therapies: Introduction of new drugs can pressure price points.
- Regulatory changes: Price regulation or importation policies impact pricing strategies.
Strategic Considerations for Stakeholders
-
Manufacturers: Focus on patent extensions, pipeline development, and strategic partnerships to maintain pricing power.
-
Investors: Monitor patent expiry dates, regulatory milestones, and market share trends for valuation.
-
Payers: Analyze price trends to negotiate better reimbursement terms and control costs.
Key Takeaways
-
Precise market size and pricing details for NDC 24208-0295 depend on the drug's indication, patent status, and competitive landscape.
-
Wholesale and retail prices have shown slight decline post-patent expiration, with future projections indicating modest decreases followed by stabilization.
-
Market dynamics are influenced by patent protection, regulatory approvals, reimbursement policies, and competitive entry.
-
Stakeholders should monitor regulatory timelines and market share shifts to optimize pricing strategies.
FAQs
1. How does patent expiration affect the drug’s price?
Patent expiration enables generic competition, leading to significant price drops—often up to 80-90%.
2. What factors drive price increases in branded drugs?
Regulatory approval for new indications, improved formulations, or market exclusivity extensions can support higher prices.
3. How do reimbursement policies influence drug pricing?
Insurers and government programs negotiate prices and formulary placement, impacting the effective cost to payers and patients.
4. When can a new biosimilar or generic enter the market for this drug?
This depends on patent status, regulatory review timelines, and biosimilar or generic developer patent challenges.
5. What is the impact of market competition on future prices?
Increased competition, especially from generics, drives prices downward. Market consolidation and new product introductions can mitigate this effect.
References
- IQVIA. (2022). The Global Use of Medicine in 2022. IQVIA Institute.
- U.S. Food and Drug Administration (FDA). (2023). Drug Approvals and Patent Data.
- PhRMA. (2022). Biopharmaceutical Research and Development: Costs, Risks, and Rewards. Pharmaceutical Research and Manufacturers of America.
- SSR Health. (2022). Prescription Brand and Generic Price Data.
- Centers for Medicare & Medicaid Services (CMS). (2023). Reimbursement and Pricing Policies.
